Clinical Compound Library

Description: - A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);- All compounds have been permitted into clinical trial phases, categorized into Phase 1, Phase 2 and Phase 3.- An effective tool for new drug screening and cell differentiation induction;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;

• SKU: TGML3400-250uL
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: L3400-250uL
• Package Unit: 250 μL
• Quantity Unit: STK